MCMCB Pro
J0586

J0586Injection, abobotulinumtoxina, 5 units

HCPCSActiveBETOS O1E

J0586 is a HCPCS Level II code for injection, abobotulinumtoxina, 5 units. It belongs to the Drugs Administered Other Than Oral Method section. Whether Medicare pays it depends on the coverage rule below.

Medicare coverage: Carrier judgment

Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.

From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.

Physician fee schedule statusE

Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).

Global period: XXX

Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.

Medically Unlikely Edits — units per day

The most units of J0586 Medicare will pay on one date of service. Bill more on a single line and it is denied. The limit is not the same in every setting, so the row that matters is the one matching the claim you are building.

practitioner
300 units
MAI 3 — Date of Service Edit: Clinical · Prescribing Information
outpatient
300 units
MAI 3 — Date of Service Edit: Clinical · Prescribing Information
DME supplier
0 — never payable
MAI 3 — Date of Service Edit: Clinical · CMS Policy

The adjudication indicator decides whether exceeding the limit is worth appealing at all: MAI 1 is a line edit you can support with documentation, MAI 3 is a date-of-service edit that is also appealable, and MAI 2 is absolute — no documentation overrides it. CMS MUE 2026Q3.

The CMS record for J0586

Long descriptor
Injection, abobotulinumtoxina, 5 units

The official wording. This is what the code means.

Short descriptor
Abobotulinumtoxina

CMS's 28-character form, which is what shows up on a remittance advice.

Added
January 1, 2010

When CMS introduced the code.

BETOS
O1E

Berenson-Eggers Type of Service — CMS's own analytic grouping.

Pricing indicator
51 — Other

Drugs.

Codes adjacent to J0586

HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J0586 is not quite right, the correct code is very often within a few positions of it.

  • J0575Buprenorphine/naloxone, oral, greater than 10 mg buprenorphine
  • J0576Injection, buprenorphine extended-release (brixadi), 1 mgterminated
  • J0577Injection, buprenorphine extended-release (brixadi), less than or equal to 7 days of therapy
  • J0578Injection, buprenorphine extended release (brixadi), greater than 7 days and up to 28 days of therapy
  • J0582Injection, bivalirudin (endo), not therapeutically equivalent to j0583, 1 mg
  • J0583Injection, bivalirudin, 1 mg
  • J0584Injection, burosumab-twza 1 mg
  • J0585Injection, onabotulinumtoxina, 1 unit
  • J0587Injection, rimabotulinumtoxinb, 100 units
  • J0588Injection, incobotulinumtoxin a, 1 unit
  • J0589Injection, daxibotulinumtoxina-lanm, 1 unit
  • J0591Injection, deoxycholic acid, 1 mg
  • J0592Injection, buprenorphine hydrochloride, 0.1 mg
  • J0593Injection, lanadelumab-flyo, 1 mg (code may be used for medicare when drug administered under direct supervision of a physician, not for use when drug is self-administered)
  • J0594injection, busulfan, 1 mg
  • J0595Injection, butorphanol tartrate, 1 mg

Questions about J0586

What is HCPCS code J0586?

J0586 is a HCPCS Level II code for injection, abobotulinumtoxina, 5 units. It sits in the Drugs Administered Other Than Oral Method section.

Does Medicare cover J0586?

The CMS HCPCS file marks J0586 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.

How is J0586 paid under the physician fee schedule?

J0586 carries PFS status code E. Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).

HCPCS Level II2026Q3-Jul· effective July 1, 2026